Ontology highlight
ABSTRACT: Background
Prostate cancer is the second most frequent cancer among males worldwide, and most patients with metastatic disease eventually develop therapy-resistant disease. Recent research has suggested the existence of cancer stem-like cells, and that such cells are behind the therapy resistance and progression.Methods
Here, we have taken advantage of the relatively quiescent nature of stem cells to identify the slow-cycling label-retaining stem cell (LRC) populations of the prostate gland. Mice were pulsed with bromodeoxyuridine (BrdU) during prostate organogenesis, and the LRC populations were then identified and characterized in 5-day-old and in 6-month-old adult animals using immunohistochemistry and immunofluorescence.Results
Quantification of LRCs in the adul
SUBMITTER: Ceder JA
PROVIDER: S-EPMC5406885 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature